Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications comparative efficacy biologics treatment moderately severely active ulcerative coliti
… on treatment response posed a challenge in evaluating comparative treatment efficacy. Other challenges included understanding long-term … identifying appropriate treatment stopping rules, finding publications reporting stratified cost and utility estimates, …
… Congress. Real-world experience and perspectives on the treatment of ulcerative colitis: results from a healthcare provider …
… (CEIFE) The Spanish Working Group on Chron’s Disease and Ulcerative Colitis (GETECCU), holds ENEIDA patient register …
… economic data collected in clinical trials Implement comparative effectiveness research Make pricing decisions … including direct, indirect, and intangible costs; cost of treatment and health-related quality of life; healthcare … Effectiveness Indirect and mixed treatment comparisons and efficacy versus effectiveness analyses Health Technology …
… Cost-Effective Second-Line ADHD Drug with Better Efficacy Reported Share on: August 25, 2016 About one-third … with ADHD have an inadequate response to initial stimulant treatment and consequently might be considered for treatment … in a 9-week, head-to-head, randomized, double-blind, active-controlled study. "Our model found that LDX is highly …
… evolving body of evidence in a particular disease or treatment area. High-quality literature reviews can help you: … , humanistic, and economic burden of a disease Determine treatment guidelines and patterns in clinical practice … economic burden, or unmet need A study to understand the efficacy of a treatment of interest versus relevant …
European Crohn's and Colitis Organisation (ECCO) 2024 Share on: Wednesday, February 21 - Saturday, February 24, 2024 Conference website Research coauthored by RTI Health Solutions experts will be presented at the European Crohn's and Colitis Organisation …
… are impacted by AD when we make decisions about care and treatment. In a groundbreaking approach, the Alzheimer’s … cross-sponsor initiative to develop data on treatment outcomes that matter most to those affected by AD … as a qualitative study to understand which potential treatment-related outcomes matter to people with AD and their …
… Willingness-to-Pay Given your product’s treatment features, do you know how much your patient’s value … dosing regimen changes from 3 times a day to 1? Length of treatment decreases to 5 days instead of 10? The delivery mechanism changes from injection to pill? Efficacy increases or side effects decrease? Our Approach Our …
… or new product’s attributes across its lifecycle—including efficacy, safety, impact on quality of life and functional … and other decision makers are willing to strike between treatment benefits and risks. MCDA provides quantitative …